Our Model

Built for Scalability, Not One-Off Success

Buffalo operates as a portfolio platform, not a single-asset fund.

Pipeline

We source programs through trusted rare disease networks, focusing on:

  • Ultra-rare Diseases
  • Validated Disease Biology
  • Clear Therapeutic Strategy
  • Patient Organizations Ready to Lead

Accelerator

We provide the expertise patient leaders need most:

  • Regulatory & FDA engagement strategy
  • Guidance on IND-enabling studies
  • Clinical trial design
  • Access to manufacturing partnerships
  • Shared operational infrastructure

Open-Source Infrastructure

Every program strengthens the whole system:

  • Trial design templates
  • Regulatory playbooks
  • Manufacturing protocols
  • Endpoint validation data

No reinvention. Faster timelines. Lower costs.

Blended Capital

Financing Aligned with Biology

Buffalo combines philanthropic early-risk capital with mission-aligned investment capital

Returns are generated through:

  • Equity
  • Royalties
  • Structured milestone payouts
  • Reinvestment into new programs